A CONTROLLED STUDY OF PRINDOLOL (VISKEN) IN HYPERTENSION
Data up to Jan 2025
Total Citations Per Year
Abstract
References (16)
Some Different Types Of Essential Hypertension
1939 • 568 citations
Treatment of Hypertension with Propranolol
1969 • 426 citations
Use of Propranolol (Inderal) in Treatment of Hypertension
1964 • 407 citations
Central Hypotensive Activity of dl- and d-Propranolol
1970 • 103 citations
VARYING HEMODYNAMIC PATTERNS IN ESSENTIAL HYPERTENSION
1965 • 102 citations
Controlled Trial of Propranolol in Hypertension
1970 • 93 citations
Essential Hypertension
1966 • 93 citations
Preliminary investigations of a new beta‐adrenoceptive receptor blocking drug, LB46, in man
1969 • 60 citations
Controlled Trial of Oxprenolol and Practolol in Hypertension
1970 • 43 citations
Studies with LB 46, a new β-receptor blocking drug
1969 • 35 citations
The effect of beta adrenergic antagonists on cardiac contractions, myofibrillar ATPase activity, high-energy phosphate stores and lipid-facilitated transfort of calciumiones.
1969 • 33 citations
A potent β-adrenoreceptor blocking drug: 4-(2-hydroxy-3-isopropylaminopropoxy)indole
1970 • 23 citations
The drug treatment of hypertension.
1971 • 8 citations
Prognosis of Hypertension
1959 • 8 citations
Prognosis in hypertension.
1970 • 6 citations
Some haemodynamic effects of LB 46 (Visken).
1970 • 2 citations
Cited By (0)
No citing papers found in database